Stockscreener 앱 받기
0.55
4.53%
-0.0261
시간 외 거래:
.55
전일 마감가:
$0.5761
열려 있는:
$0.5392
하루 거래량:
22,738
Relative Volume:
0.44
시가총액:
$2.76M
수익:
$4.05M
순이익/손실:
$-3.19M
주가수익비율:
-0.5335
EPS:
-1.0309
순현금흐름:
$-169.60K
1주 성능:
-13.24%
1개월 성능:
-12.86%
6개월 성능:
-72.29%
1년 성능:
-80.41%
1일 변동 폭
$0.5392
$0.63
1주일 범위
$0.5392
$0.64
52주 변동 폭
$0.5003
$3.10
China Pharma Holdings Inc. Stock (CPHI) Company Profile
명칭
China Pharma Holdings Inc.
전화
86 898 6681 1730
주소
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.55 | 2.89M | 4.05M | -3.19M | -169.60K | -1.0309 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 56.96B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.99 | 49.54B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.23 | 45.90B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.44 | 34.48B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
527.00 | 23.24B | 3.18B | 1.33B | 1.04B | 27.90 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2010-01-08 | 개시 | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. 주식(CPHI)의 최신 뉴스
China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative - simplywall.st
Market Outlook: Will China Pharma Holdings Inc be affected by tariffs2026 Key Lessons & Safe Swing Trade Setups - baoquankhu1.vn
Assessing China Medical System (SEHK:867) Valuation After A Recent Share Price Pullback - simplywall.st
Investment Recap: How correlated is NCDL to the S P500Long Setup & Weekly Momentum Stock Picks - baoquankhu1.vn
Bearish Setup: How does China Pharma Holdings Inc perform in inflationary periods2026 Winners & Losers & Low Drawdown Investment Strategies - baoquankhu1.vn
Volume Recap: What are the analyst revisions for Amdocs LimitedIs CTEV stock a good investment in YEARProduct Launch & AI Based Buy and Sell Signals - baoquankhu1.vn
Can China Pharma Holdings Inc lead its sector in growth2026 Momentum Check & Target Return Focused Picks - baoquankhu1.vn
Will Pony AI Inc. Depositary Receipt stock continue dividend increases2026 Support & Resistance & Reliable Intraday Trade Plans - Naître et grandir
How GreenTree Hospitality Group Ltd. American stock performs during market turbulencePortfolio Risk Report & Weekly Return Optimization Plans - Naître et grandir
Volume Report: Is Central Plains Bancshares Inc backed by strong institutional buyingRisk Management & Community Consensus Trade Alerts - baoquankhu1.vn
Is Southland Holdings Inc. Equity Warrant stock a dividend growth opportunityIPO Watch & Risk Controlled Daily Trade Plans - Naître et grandir
Fed Watch: Is China Pharma Holdings Incs ROE strong enoughJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
Trade Recap: Can China Pharma Holdings Inc expand into new marketsJuly 2025 Intraday Action & Community Consensus Trade Signals - baoquankhu1.vn
China Pharma Expands R&D Portfolio With Patent Acquisition - TipRanks
Quarterly Risk: Can China Pharma Holdings Inc keep up with sector leadersJuly 2025 WrapUp & Fast Gain Stock Trading Tips - baoquankhu1.vn
getLinesFromResByArray error: size == 0 - mfd.ru
Naproxen Patches Market Growth Fueled by Shift from Oral Nsaids, Forecast to 2035News and Statistics - IndexBox
CPHI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
GLMD PE Ratio & Valuation, Is GLMD Overvalued - Intellectia AI
Inflation Data: Is Blackstone Inc affected by consumer sentimentQuarterly Earnings Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Risk Check: Is China Pharma Holdings Inc part of any ETFQuarterly Growth Report & Smart Investment Allocation Insights - baoquankhu1.vn
Risk Analysis: Can NESRW lead its sector in growthShare Buyback & Trade Opportunity Analysis - baoquankhu1.vn
BIT Capital GmbH Reduces Holdings in BridgeBio Pharma, Inc. $BBIO - Defense World
CPHI Should I Buy - Intellectia AI
Winners Losers: Is GoldMining Inc part of any ETFMarket Sentiment Summary & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
The China factor: US pharma group campaigns for increased competitiveness - Yahoo Finance
PAPLD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
AI Drug Discovery Push And New Kidney Drug Trial Could Be A Game Changer For China Medical System Holdings (SEHK:867) - simplywall.st
Profit Review: Should I set a stop loss on SGRPLayoff News & Technical Buy Zone Confirmation - baoquankhu1.vn
00863 Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Most and least shorted healthcare stocks with up to $2B market cap - Seeking Alpha
Plasma Fractionation Market Size and Forecast Research Report 2026 to 2035 - Insightace Analytic
Can China Pharma Holdings Inc. stock maintain growth trajectory2025 Investor Takeaways & Long-Term Safe Return Strategies - mfd.ru
Will China Pharma Holdings Inc. stock maintain momentum in 2025Gap Up & Verified Entry Point Detection - mfd.ru
What margin trends mean for China Pharma Holdings Inc. stockJuly 2025 Trends & Technical Pattern Based Signals - mfd.ru
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
China Medical System Expands AI Drug Pipeline As Valuation Gap Persists - simplywall.st
Published on: 2026-02-12 19:55:00 - mfd.ru
Is Gold Royalty Corp. currently under institutional pressure2025 Top Gainers & Stock Portfolio Risk Control - mfd.ru
Is China Pharma Holdings Inc. stock trending bullish2025 Key Highlights & AI Driven Price Predictions - mfd.ru
What’s next for Athira Pharma Inc. stockCPI Data & Pattern Based Trade Signal System - mfd.ru
Can China Pharma Holdings Inc. expand its profit marginsTrade Risk Report & Long-Term Safe Investment Ideas - mfd.ru
China Pharma Acquires Topiroxostat Patent Via Equity Issuance - The Globe and Mail
China Pharma to acquire patent through $8.82 million stock issuance By Investing.com - Investing.com UK
China Pharma to acquire patent through $8.82 million stock issuance - Investing.com Nigeria
Risk Check: Is PGEN stock a hidden gemPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Reactions: Can China Pharma Holdings Inc stock outperform in a bear marketJuly 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Ascentage Pharma Receives Clearance from China’s CDE for New Drug - Yahoo Finance
Ascentage Pharma Group International Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - marketscreener.com
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
China Pharma Holdings Inc. (CPHI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.77%
자본화:
|
볼륨(24시간):